News for hackers. Stuff that matters.
Re:Compass Pathways' Phase IIb psilocybin trial shows reduce... by arcticbull on Tuesday November 09, 2021 @07:18PM (#29169427)
> Very small, can't generalize results based on such a small number.

This comes up pretty often, but how many subjects do you need to know getting punched in the face hurts? It's absolutely possible to get statistically significant data from 233 patients, what matters is how the study is designed.

Re:Compass Pathways' Phase IIb psilocybin trial shows reduce... by tayo42 on Tuesday November 09, 2021 @11:44PM (#29171166)
Yeah For surveying large populations I think you only need around 270 samples to get 90% acuuracy. Something like that, might have mixed up at word it's been awhile since I did stats.